SciSparc Ltd.旗下子公司Neurothera Labs,于耶鲁大学儿童研究中心正式启动一项IIb期临床试验——该试验针对的是一种首创性图雷特综合征治疗方案。
SciSparc Ltd.旗下子公司Neurothera Labs,于耶鲁大学儿童研究中心正式启动一项IIb期临床试验——该试验针对的是一种首创性图雷特综合征治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.